CTSO
Closed
Cytosorbents Crp
1.29
+0.01 (+0.78%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 1.28
Day's Range: 1.2523 - 1.3
Send
sign up or login to leave a comment!
When Written:
3.37
Cytosorbents CRP (C-reactive protein) is a medical device used for the treatment of sepsis and other critical care conditions. It is a highly porous polymer bead-based adsorbent that can effectively remove inflammatory mediators, including CRP, from the bloodstream. CRP is a protein produced by the liver in response to inflammation and infection. Elevated levels of CRP in the bloodstream can indicate the presence of inflammation, infection, or tissue damage. By removing CRP and other inflammatory mediators, Cytosorbents CRP can help reduce the severity of sepsis and other critical care conditions, improve patient outcomes, and reduce healthcare costs. The device is approved for use in Europe and is currently undergoing clinical trials in the United States.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!